Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Stability of Lisinopril Syrup (2 mg/mL) Extemporaneously Compounded from Tablets

Author(s):  Rose Deidra J, Webster Andrew A, English Brett A, McGuire J Michael

Issue:  Sep/Oct 2000 - Compounding for Immune System Disorders
View All Articles in Issue

Page(s):  398-399

Stability of Lisinopril Syrup (2 mg/mL) Extemporaneously Compounded from Tablets Page 1
Stability of Lisinopril Syrup (2 mg/mL) Extemporaneously Compounded from Tablets Page 2

Download in electronic PDF format for $65

Abstract:  The stability of lisinopril syrup (2 mg/mL) extemporaneously compounded from tablets was investigated. Zestril® tablets (Lot CSC201, Zeneca Pharmaceuticals, Wilmington, Del) were crushed, dissolved in water, filtered, and diluted with syrup NF to a final nominal concentration of 2 mg/mL. The solution was then equally divided among amber-colored prescription bottles and was stored at 5°C and 23°C. During the 30-day study period, samples were extracted by means of a water:methanol mix, and the concentration of lisinopril was determined by a stability-indicating, highperformance liquid chromatography assay procedure. Stability was also determined by pH measurements and visual inspection for color or clarity change. Over the 30- day study period, the percentage of the initial lisinopril concentration remained between 99.42% ± 0.19% and 95.68% ± 1.5% for the 5°C samples and 98.83% ± 0.46% and 96.48% ± 0.62% for the 23°C samples.

Related Keywords: lisinopril syrup, stability, liquid lisinopril, storage

Related Categories: PEER-REVIEWED, STABILITIES, COMPATIBILITIES

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Stability of Lisinopril Syrup (2 mg/mL) Extemporaneously Compounded from Tablets
Rose Deidra J
, Webster Andrew A, English Brett A, McGuire J Michael
Sep/Oct 2000
Pg. 398-399

Lisinopril 1-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2006
Pg. 302

The Stability of Lisinopril as an Extemporaneous Syrup
Webster Andrew A
, English Brett A, Rose Deidra J
Sep/Oct 1997
Pg. 352-353

Lisinopril 1-mg/mL, Sodium Citrate, and Citric Acid Oral Liquid
Allen Loyd V Jr
Sep/Oct 2006
Pg. 386

Lisinopril 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jul/Aug 2020
Pg. 318

Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions
Polonini Hudson C
, Loures Sharlene, de Araujo Edson Peter, Brandão Marcos Antônio F, Ferreira Anderson O
Sep/Oct 2016
Pg. 426-434

Oral Liquid Vehicles, Featured Excipient:
Allen Loyd V Jr
Jan/Feb 2001
Pg. 65-67

pH Stability of Injectable Fentanyl, Bupivacaine, or Clonidine Solution or a Ternary Mixture in 0.9% Sodium Chloride in Two Types of Polypropylene Syringes
Jappinen Annaliisa L
, Kokki H, Rasi A S, Naaranlahti Toivo J
Nov/Dec 2002
Pg. 471-474

Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution)
Voudrie Mark A II
, Allen D Brett
Jan/Feb 2010
Pg. 82-85

Stability of Verapamil Hydrochloride in SyrSpend SF Compared to Sorbitol Containing Syrup and Suspending Vehicles
Voudrie Mark A
, Alexander Bridget, Allen D Brett
May/Jun 2011
Pg. 255-258

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions